United Therapeutics rallies after favorable court ruling

|About: United Therapeutics Co... (UTHR)|By:, SA News Editor

Shares of United Therapeutics (UTHR +23.1%) jump on 5x surge in volume after a court rules that Sandoz (NVS +0.3%) failed to prove that United's '007 and '117 Remodulin (treprostinil) patents are invalid and that United proved that Sandoz's ANDA will infringe on patent '117.

Remodulin accounted for almost 45% of United's 1H sales of $612.2M.